Denali Capital Acquisition 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Lei Huang

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	2.6yrs

최근 관리 업데이트

업데이트 없음

Recent updates

CEO

Lei Huang (53 yo)

no data

테뉴어

Mr. Lei Huang is Co-Chief Executive Officer and Director at TradeUP 88 Corp. since April 07, 2021. Mr. Huang is Chief Executive Officer and Director of Denali Capital Acquisition Corp. He served as Chief E...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Lei Huang	CEO & Director	no data	데이터 없음	데이터 없음
Kevin Dean Vassily	Independent Director	2.6yrs	데이터 없음	0.71% $ 234.2k
Huifeng Chang	Independent Director	2.6yrs	데이터 없음	0.71% $ 234.2k
Zhimin Mao	Independent Director	2.6yrs	데이터 없음	0.71% $ 234.2k

2.6yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: DECA.U 의 이사회는 경험(평균 재직 기간 2.6 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Denali Capital Acquisition 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Recent updates

Denali Capital Acquisition Corp. announced delayed 10-Q filing

Denali Capital Acquisition Corp. announced delayed 10-Q filing

Denali Capital Acquisition Corp. announced that it has received $0.18 million in funding from Denali Capital Global Investments LLC

Semnur Pharmaceuticals, Inc. signed a letter of intent to acquire Denali Capital Acquisition Corp. (NasdaqGM:DECA) in a reverse merger transaction for approximately $2 billion on July 2, 2024.

Longevity Biomedical, Inc. terminated the letter of intent to acquire Denali Capital Acquisition Corp. (NasdaqGM:DECA) from Denali Capital Global Investments LLC and others in a reverse merger transaction.

Denali Capital Acquisition Corp. announced delayed 10-Q filing

Denali Capital Acquisition Corp. announced that it expects to receive $0.45 million in funding from FutureTech Capital LLC

Denali Capital Acquisition Corp. announced that it expects to receive $0.45 million in funding from FutureTech Capital LLC

Longevity Biomedical, Inc. entered into an agreement to acquire Denali Capital Acquisition Corp. (NasdaqGM:DECA) from Denali Capital Global Investments LLC and others for approximately $130 million in a reverse merger transaction.

Denali Capital Acquisition Corp. announced delayed 10-Q filing

Denali Capital Acquisition Corp. announced that it has received $5.1 million in funding from Denali Capital Global Investments LLC

Denali Capital Acquisition Corp. has completed an IPO in the amount of $75 million.

Denali Capital Acquisition Corp. has completed an IPO in the amount of $75 million.

CEO

테뉴어

이사회 구성원

평균 재임 기간

평균 연령